Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    1.

    Hormone therapy to prevent disease and prolong life in postmenopausal women.

    Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR.

    Ann Intern Med. 1992 Dec 15;117(12):1016-37. Review.PMID: 1443971 [PubMed - indexed for MEDLINE]Related articles

    2.

    Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

    JAMA. 2002 Jul 17;288(3):321-33.PMID: 12117397 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Patient-specific decisions about hormone replacement therapy in postmenopausal women.

    Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, Orr RK, Wong JB.

    JAMA. 1997 Apr 9;277(14):1140-7.PMID: 9087469 [PubMed - indexed for MEDLINE]Related articles

    4.

    Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.

    Col NF, Pauker SG, Goldberg RJ, Eckman MH, Orr RK, Ross EM, Wong JB.

    Arch Intern Med. 1999 Jul 12;159(13):1458-66.PMID: 10399897 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.

    Whittington R, Faulds D.

    Pharmacoeconomics. 1994 Jun;5(6):513-54. Review.PMID: 10147266 [PubMed - indexed for MEDLINE]Related articles

    6.

    Postmenopausal hormone replacement therapy: scientific review.

    Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

    JAMA. 2002 Aug 21;288(7):872-81. Review.PMID: 12186605 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Postmenopausal hormone therapy: cardiovascular risks.

    [No authors listed]

    Prescrire Int. 2003 Apr;12(64):65-9.PMID: 12674130 [PubMed - indexed for MEDLINE]Related articles

    8.

    Postmenopausal hormone replacement therapy--clinical implications.

    Ravn SH, Rosenberg J, Bostofte E.

    Eur J Obstet Gynecol Reprod Biol. 1994 Feb;53(2):81-93. Review.PMID: 8194655 [PubMed - indexed for MEDLINE]Related articles

    9.

    Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

    Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

    Am J Epidemiol. 2009 Jul 1;170(1):12-23. Epub 2009 May 25.PMID: 19468079 [PubMed - indexed for MEDLINE]Related articles

    10.

    Validation of a decision model for preventive pharmacological strategies in postmenopausal women.

    Perreault S, Levinton C, Laurier C, Moride Y, Ste-Marie LG, Crott R.

    Eur J Epidemiol. 2005;20(1):89-101.PMID: 15756909 [PubMed - indexed for MEDLINE]Related articles

    11.

    Postmenopausal hormone therapy: less favourable risk-benefit ratios in healthy Dutch women.

    Moerman CJ, Van Hout BA, Bonneux L, Witteman JC.

    J Intern Med. 2000 Aug;248(2):143-50.PMID: 10947893 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evaluating the benefits and risks of postmenopausal hormone therapy.

    Cummings SR.

    Am J Med. 1991 Nov 25;91(5B):14S-18S. Review.PMID: 1750410 [PubMed - indexed for MEDLINE]Related articles

    13.

    Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.

    Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C.

    Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1724-31.PMID: 16030108 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

    Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee.

    JAMA. 2004 Apr 14;291(14):1701-12.PMID: 15082697 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Estrogen-progestin replacement therapy and endometrial cancer.

    Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM.

    J Natl Cancer Inst. 1997 Aug 6;89(15):1110-6.PMID: 9262248 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

    Colditz GA.

    J Natl Cancer Inst. 1998 Jun 3;90(11):814-23. Review.PMID: 9625169 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Estrogen replacement therapy in the elderly.

    Paganini-Hill A.

    Zentralbl Gynakol. 1996;118(5):255-61. Review.PMID: 8701621 [PubMed - indexed for MEDLINE]Related articles

    18.

    Breast cancer risk with postmenopausal hormonal treatment.

    Collins JA, Blake JM, Crosignani PG.

    Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331. PMID: 16150813 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Risks, benefits and costs of hormone replacement therapy in menopause]

    Gaspard U.

    Rev Med Liege. 1998 May;53(5):298-304. French. PMID: 9689887 [PubMed - indexed for MEDLINE]Related articles

    20.

    Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.

    van Leeuwen FE.

    Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Review.PMID: 1801500 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data